Granted Patent
B2
US 8,377,646 · App. 13/243,593 · Granted Feb 19, 2013
Beta-2 microglobulin as a biomarker for peripheral artery disease
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides β2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
Claims (5)
1. A method for qualifying peripheral artery disease status in a subject comprising:
(a) measuring cystatin C in a biological sample from the subject; and
(b) correlating the measurement or measurements with peripheral artery disease versus non-peripheral artery disease.
2. The method of claim 1 , further comprising measuring β2-microglobulin.
3. The method of any of claim 1 or claim 2 , wherein said measurement or measurements of a biomarker is performed using an immunoassay.
Assignments (1)
CONFIRMATORY LICENSE
Recorded Sep 17, 2013
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031218/0542 →
Continuity (5)
Provisional Application
60781403
· Mar 11, 2006
Provisional Application
60863951
· Nov 1, 2006